Search by Drug Name or NDC
NDC 31722-0688-46 Rufinamide 40 mg/mL Details
Rufinamide 40 mg/mL
Rufinamide is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is RUFINAMIDE.
MedlinePlus Drug Summary
Rufinamide is used with other medication(s) to control seizures in people who have Lennox-Gastaut syndrome (a severe form of epilepsy that begins during childhood and causes several types of seizures, behavioral disturbances, and developmental delays). Rufinamide is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
Related Packages: 31722-0688-46Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Rufinamide
Product Information
| NDC | 31722-0688 |
|---|---|
| Product ID | 31722-688_0d914e03-3610-c662-e063-6294a90a5430 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Rufinamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rufinamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/mL |
| Substance Name | RUFINAMIDE |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216841 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 31722-0688-46 (31722068846)
| NDC Package Code | 31722-688-46 |
|---|---|
| Billing NDC | 31722068846 |
| Package | 1 BOTTLE in 1 CARTON (31722-688-46) / 460 mL in 1 BOTTLE |
| Marketing Start Date | 2023-12-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |